IBM has announced a new operating model for the biopharmaceutical industry that leverages connected data and agentic AI to improve operations at scale. The approach aims to transform how life sciences companies manage and utilize their data infrastructure. Details regarding specific implementation strategies and expected outcomes were not fully elaborated in the available description.